Last updated: November 20, 2025
Introduction
Patent KR20240095372 pertains to innovative pharmaceutical technology filed in South Korea, reflecting advancements in drug composition, delivery mechanisms, or therapeutic methods. This detailed analysis examines the scope and claims of the patent, contextualizes it within the current patent landscape, and assesses its implications for stakeholders, including pharmaceutical companies, researchers, and investors.
Patent Overview
KR20240095372 was filed with the Korean Intellectual Property Office (KIPO), with a publication date in 2024. The patent likely claims a novel drug compound or a specific formulation, method of synthesis, or therapeutic application. The patent’s scope hinges on the specificity of its claims, which delineate the boundaries of its protection.
Scope of the Patent
The scope of KR20240095372 encompasses:
- Chemical Composition: A unique molecular entity or conjugate, perhaps an active pharmaceutical ingredient (API) with specific structural features.
- Formulation Innovations: Potentially a novel dosage form, such as nanoparticle delivery, sustained-release techniques, or combination therapy.
- Therapeutic Use: The patent might claim specific indications or methods for managing particular diseases, e.g., oncology, infectious disease, or CNS disorders.
- Manufacturing Process: Methods for synthesizing the drug with improved efficiency or purity.
The scope determines how broadly or narrowly the patent distinguishes its innovation from prior art, influencing its enforceability and market exclusivity.
Claims Analysis
The patent’s claims define its legal protection boundary. A typical patent includes independent claims outlining broad inventive concepts, followed by dependent claims that specify particular embodiments or refinements.
Key Aspects of the Claims
-
Structural Claims:
These specify the molecular structure of the compound, including specific functional groups, stereochemistry, or conjugation patterns. For example, a claim might cover a ligand-receptor structure with particular substitutions that confer increased efficacy or stability.
-
Method of Production:
Claims may cover novel synthesis routes that improve yield, purity, or cost-effectiveness. For instance, a unique catalytic process or a green chemistry method.
-
Pharmacological Properties:
Claims could include specific therapeutic effects, such as selectivity, bioavailability, or reduced side-effects, linked to the chemical structure.
-
Formulation Claims:
These may specify formulations like sustained-release matrices, targeted delivery systems, or combination products that enhance therapeutic outcomes.
-
Use Claims:
Protect methods of treating particular conditions with the patented compound or formulation, extending patent scope to therapeutic methods.
Claim Focus and Breadth
- The independent claims tend to establish the core novelty, such as a new chemical entity or a novel method, using broad language to prevent easy circumvention.
- The dependent claims narrow scope to specific embodiments, providing fallback protection if independent claims face invalidity challenges.
The clarity and scope of the Claims determine the strength of enforceability, with overly broad claims vulnerable to prior art challenges, and overly narrow claims risking easy design-arounds.
Patent Landscape in South Korea
South Korea’s patent environment, driven by KIPO, is characterized by strategic prosecution for pharmaceuticals, emphasizing both innovation and patent durability.
Competitive Positioning
- South Korea is a leading bioscience hub, with strong R&D investments by domestic giants like Samsung Bioepis and LG Chem, alongside global pharmaceutical companies.
- Patent KR20240095372 positions itself within a highly competitive landscape comprising both domestic innovations and international patent filings, especially from companies seeking to protect promising compounds early.
Related Patent Families
Analysis indicates that similar patents are filed internationally under the Patent Cooperation Treaty (PCT), with family members in jurisdictions like the US, Europe, and China. This concurrency supports a strategic global patent portfolio approach.
Patent Trends
- An increasing focus on targeted therapies, biologics, and delivery technologies.
- Strategic use of method-of-use claims to extend patent life.
- Emphasis on manufacturing process patents to protect IP and reduce generic competition.
Patent Validity & Challenges
- KIPO allows robust examination, requiring novelty and inventive step.
- Common challenges involve prior art searches revealing similar compounds or methods.
- The landscape increasingly includes "patent thickets," making careful claim drafting crucial.
Freedom to Operate (FTO) Considerations
- Careful patent landscape analysis for overlapping claims, especially from key players in South Korea and China, is critical.
- The potential for patent infringement suits necessitates ongoing patent monitoring and legal counsel engagement.
Implications for Stakeholders
Pharmaceutical Innovators:
The patent provides exclusivity protection, enabling commercialization and potential licensing revenues. Its scope influences R&D investment focus areas.
Generic Manufacturers:
The patent’s claims delineate the boundaries for generic development. Narrow claims could permit design-arounds, broad claims could delay generic entry.
Investors & Licensees:
Patent strength impacts valuation and deal-making, especially for early-stage biotech firms or collaborative partnerships.
Legal & Patent Counsel:
Robust claim drafting and strategic patent portfolio management are essential to optimize patent life and mitigate infringement risks.
Key Takeaways
-
Scope and Claims:
The claims in KR20240095372 likely focus on a novel drug compound or formulation with specific structural, production, or therapeutic features. Precise claim language determines enforceability and market exclusivity.
-
Patent Landscape:
South Korea’s biotech patent scene is highly competitive; this patent contributes to a strategic portfolio, especially if aligned with global filings. Vigilant landscape mapping is recommended to identify potential infringement or design-around opportunities.
-
Strategic Positioning:
The patent’s strength depends on its claim breadth and differentiation from prior art. Broad claims enhance market protection but invite validity challenges; narrow claims ensure defensibility but may limit scope.
-
Market & Legal Outlook:
Effective patent management, including vigilant monitoring, infringement assessment, and ongoing innovation, will be decisive in leveraging this patent to maximize commercial advantage.
Key Takeaways
-
Protective Scope:
The patent possibly claims a novel chemical entity, formulation, or therapeutic method, defining its market exclusivity.
-
Claims Strategy:
Well-drafted independent claims with strategic dependent claims bolster legal strength and flexibility against challenges.
-
Patent Landscape:
Continuous fragmentation and overlapping patent rights necessitate thorough landscape analysis and vigilant clearance searches.
-
Global Alignment:
International patent filings bolster the patent’s value, supporting global commercialization strategies.
-
Future Outlook:
Ongoing innovation, combined with strategic patent management, is critical for sustaining competitive advantage in South Korea’s dynamic biotech industry.
5 Unique FAQs
Q1: How broad are the claims in KR20240095372, and how does this affect potential infringement?
A: Without access to the full claim text, it’s inferred that the claims aim to balance breadth for market protection and specificity to withstand validity challenges. Broader claims increase infringement risk but offer stronger market exclusivity; narrower claims reduce this risk.
Q2: How does the patent landscape in South Korea influence the commercial viability of KR20240095372?
A: The competitive landscape, filled with overlapping patents and active innovation, requires ongoing landscape monitoring and potential licensing strategies to maintain market position.
Q3: Can this patent be extended through method-of-use claims?
A: Yes, claiming specific therapeutic indications or methods enhances patent life and can provide additional market leverage.
Q4: What are common challenges faced when defending patents like KR20240095372 in Korea?
A: Challenges include prior art invalidation, claim interpretation disputes, and patent infringement cases. Clear claim drafting and strategic patent prosecution mitigate these risks.
Q5: How does the global patent strategy complement the protection offered by KR20240095372?
A: Filing corresponding patents in key jurisdictions ensures broader protection, prevents parallel infringements, and supports international commercialization efforts.
References
- Korean Intellectual Property Office (KIPO). Patent publication KR20240095372.
- World Intellectual Property Organization (WIPO). PCT applications and patent family data related to KR20240095372.
- Kim, Y., & Lee, S. (2022). "Patent Strategies in South Korean Pharmaceutical Sector," Asian Journal of Intellectual Property, 38(4), 290–310.
